Daily MailStem cells could prevent transplant organ rejectionPHG FoundationThe use of stem cells alongside kidney transplants has allowed a small number of patients to eschew the normal drugs required to prevent transplant rejection. Research published…
USA TODAYCells may spare kidney transplant rejection drugsTriValley CentralBy LAURAN NEERGAARD AP Medical Writer WASHINGTON — An experimental technique seems to be freeing some kidney transplant patients from having to take anti-rejection drugs. Rese…
'Psych' Recap: 'Heeeeere's Lassie' Parodies 'The Shining,' 'Ghostbusters,' MoreGather Celebs News ChannelTurns out she has acute rejection disorder, and she killed the previous two tenants when they spurned her. Afra…
ABC NewsCells may spare kidney transplant rejection drugsDAWN.comAP Researchers transplanted certain cells from the kidney donor's bone marrow along with the new organ. Five of eight transplant recipients who tried the method so far were off immune…
USA TODAYCells may spare kidney transplant rejection drugsUSA TODAYWASHINGTON – An experimental technique seems to be freeing some kidney transplant patients from having to take anti-rejection drugs. Rachel Ramirez sits in a chair at Desert Valley Di…
Cells may spare kidney transplant rejection drugsBoston.comBy Lauran Neergaard AP Medical Writer / March 7, 2012 WASHINGTON—An experimental technique seems to be freeing some kidney transplant patients from having to take anti-rejection drugs. Resear…
Cells may spare kidney transplant rejection drugsThe Associated PressWASHINGTON (AP) — An experimental technique seems to be freeing some kidney transplant patients from having to take anti-rejection drugs. Researchers transplanted certain cells from…
Cells may spare kidney transplant rejection drugsWRGBWASHINGTON (AP) — An experimental technique seems to be freeing some kidney transplant patients from having to take anti-rejection drugs. Researchers transplanted certain cells from the kidney donor…
abc11.comAltered Stem Cells Limit Transplant RejectionWebMDBy Salynn Boyles March 7, 2012 — New research holds the promise of freeing many organ transplant patients from a lifetime of anti-rejection drugs. In the first study of its kind, eight kidney …
Rigel Announces Fourth Quarter and Year End 2011 Financial ResultsBradenton HeraldIn the fourth quarter of 2011, Rigel initiated Phase 1 clinical studies of R548 with a focus on its potential to treat transplant rejection and other immune system disord…